TRIM63 and cancer: Thus, both the NF-κB/HIF-1α and IRF/TLR/STAT signaling pathways could be targeted in cancer to prevent cancer cells from persistently shifting macrophages into TAMs, which favor cancer progression within the tumor microenvironment.